Compositions and methods for silencing marburg virus gene expression
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 19, 2017
Issued Date -
N/A
app pub date -
Aug 21, 2015
filing date -
Aug 21, 2014
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides compositions comprising siRNA molecules that target Marburg virus (MARV) gene expression, lipid particles comprising one or more (e.g., a combination) of the siRNA molecules, and methods of delivering and/or administering the lipid particles, for the purposes of treating MARV infection.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully